[Phosphate treatment in hypercalcemia].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D002118:Calcium / Q000097:blood / Q000652:urine; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D006934:Hypercalcemia / Q000150:complications / Q000188:drug therapy*; D006961:Hyperparathyroidism / Q000097:blood / Q000150:complications / Q000652:urine; D007275:Injections, Intravenous; D007669:Kidney Calculi; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications; D010710:Phosphates / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D010758:Phosphorus / Q000652:urine; D013997:Time Factors; D014807:Vitamin D / Q000009:adverse effects; D014882:Water-Electrolyte Balance
D010710:Phosphates; D014807:Vitamin D; D010758:Phosphorus; D002118:Calcium
Phosphatbehandlung bei Hypercalcämie.